• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Roles of ROS-sensitive TRP channels in generation and prolongation of pain and dysesthesia

Research Project

  • PDF
Project/Area Number 26293019
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field Pharmacology in pharmacy
Research InstitutionKyoto University

Principal Investigator

Nakagawa Takayuki  京都大学, 医学(系)研究科(研究院), 准教授 (30303845)

Co-Investigator(Renkei-kenkyūsha) SHIRAKAWA Hisashi  京都大学, 大学院薬学研究科, 准教授 (50402798)
MORI Yasuo  京都大学, 大学院工学研究科, 教授 (80212265)
Research Collaborator SO Kanako  
DOGISHI Koji  
ISAMI Koichi  
MIYAKE Takahito  
KODERA Mizuki  
OYAMA Shohei  
SUKEISHI Asami  
TEI Yuna  
HIYAMA Haruka  
Project Period (FY) 2014-04-01 – 2017-03-31
KeywordsTRPチャネル / 活性酸素種 / 痛み / しびれ / オキサリプラチン / TRPA1 / TRPM2 / 慢性膀胱炎
Outline of Final Research Achievements

It is well known that reactive oxygen species (ROS) nonspecifically impairs sensory neurons, which generate unpleasant abnormal sensation, such as pain and dysesthesia. However, recent evidence suggest ROS can act on specific targets to induce physiological and pathological responses. In this study, we have shown that ROS-mediated activation of some ROS-sensitive TRP channels specifically contribute to the generation and prolongation of pain and dysesthesia. 1) TRPM2 mainly expressed on peripheral immune cells and spinal glial cells causes a wide range of pain mouse models, including inflammatory and neuropathic pain. 2) ROS-mediated activation of TRPA1, expressed on sensory neurons contributes to oxaliplatin-induced acute peripheral neuropathy and transient hindlimb ischemia/reperfusion-induced spontaneous dysesthesia, which are based to the inhibition of prolyl hydroxylase. 3) TRPA1 is involved in long-lasting cystitis model induced by intravesical injection of H2O2.

Free Research Field

薬理学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi